Selective serotonin reuptake inhibitors

BMJ

Volumn 330, Issue 7488, 2005, Pages 420-421

  Peveler, Robert ^a   Kendrick, Tony ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; PLACEBO; SEROTONIN UPTAKE INHIBITOR; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; BUSPIRONE; TRICYCLIC ANTIDEPRESSANT AGENT;

DEPRESSION; HUMAN; NOTE; AGITATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; EVIDENCE BASED MEDICINE; GENERAL PRACTICE; LETTER; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SLEEP; SYSTEMATIC REVIEW;

ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER; HUMANS; PLACEBO EFFECT; SEROTONIN UPTAKE INHIBITORS;

EID: 13844312472     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.330.7488.420-b     Document Type: Letter

References (5)

1. Geddes JR, Cipriani A. Selective serotonin re-uptake inhibitors remain useful drugs which need careful monitoring. BMJ 2004; 329: 809–10. (9 October.)
2. National Institute for Clinical Excellence. Depression:management of depression in primary and secondary care. Clinical guideline 23. London: NICE, 2004. www.nice.org.uk/pdf/CG023quickrefguide.pdf (accessed 11 Feb 2005).
3. Paykel ES, Hollyman JC, Freeling P, Sedgwick P. Predictors of therapeutic benefit from amitriptyline in mild depression: a general practice placebo-controlled trial. J Affective Dis 1988; 14: 83–95
4. Judd LL, Rapaport MH, Yonkers KA, Rush AJ, Frank E, Thase ME, et al. Randomized placebo-controlled trial of fluoxetine for acute treatment of minor depressive disorder. Am J Psychiatry 2004; 161: 1864–71.
5. Barrett JE, Williams JW, Oxman TE, Frank E, Katon W, Sullivan M, et al. Treatment of dysthymia and minor depression in primary care: a randomized trial in patients aged 18 to 59 years. J Fam Pract 2001; 50: 405–12.